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Abstract 14 
Maternal diabetes and obesity are characterised by elevated blood glucose, insulin and 15 
lipids, resulting in up-regulation of specific fuel sensing and stress signalling pathways. 16 
We have previously demonstrated that separately, up-regulation of the hexosamine 17 
biosynthetic pathway (HBP, under hyperglycaemic conditions) and endoplasmic 18 
reticulum (ER) stress (due to hyperlipidemia) pathways reduce blastocyst development 19 
and alter oocyte metabolism. In order to begin to understand how both glucose and lipid 20 
metabolic disruptions influence oocyte developmental competence, this study exposed 21 
mouse cumulus-oocyte complexes to hyperglycaemia (30 mM) and/or lipid (40 M) 22 
and examined the effect on embryo development. The presence of glucosamine (a 23 
hyperglycaemic mimetic) or increased lipid during in vitro maturation severely 24 
perturbed blastocyst development (P<0.05). Hyperglycaemia, GlcN, and 25 
hyperglycaemia + lipid treatments significantly increased HBP activity, increasing total 26 
O-linked glycosylation (O-GlcNAcylation) of proteins (P<0.0001). All the treatments 27 
also induced ER stress pathways, indicated by the expression of specific ER stress 28 
genes. The expression of HBP enzymes glutamine:fructose-6-phosphate 29 
amidotransferase 2 (Gfpt2) and O-linked -N-acetylglucosaminyltransferase (Ogt) were 30 
repressed following lipid treatment (P<0.001). These findings partially implicate the 31 
mechanism of O-GlcNAcylation and ER-stress as likely contributors to compromised 32 
fertility of obese women. 33 
 34 
Keywords: Cumulus-oocyte complex, embryo, hexosamine biosynthesis pathway, 35 
endoplasmic reticulum stress, hyperglycaemia, hyperlipidemia 36 
  37 
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Introduction 38 
Maternal obesity, a condition associated with elevated plasma insulin, glucose, and lipid, 39 
is a global health problem that affects an increasing number of women of reproductive 40 
age (AIHW 2012). Obesity is also a contributory factor to Type II diabetes, 41 
characterised by hyperglycaemia (elevated blood glucose level) and hyperlipidemia. 42 
These conditions have been associated with higher risk of sub-fertility and pregnancy 43 
complications; including increased risk of anovulation, preeclampsia, miscarriage, and 44 
spontaneous abortion (Jungheim and Moley 2010). They are also associated with 45 
increased incidence of congenital anomalies, macrosomia and stillborns (Sirimi and 46 
Goulis 2010). Moreover, these complications extend beyond neonatal health, into 47 
childhood and adulthood (Dabelea and Crume 2011; Heerwagen, Miller et al. 2010; 48 
O'Reilly and Reynolds 2013). 49 
 50 
The peri-conception period (including the final stages of oocyte development and 51 
fertilisation) is particularly sensitive to the maternal metabolic environment.  For 52 
example, zygotes collected from oviducts of diabetic mice and subsequently transferred 53 
to normoglycemic recipients have retarded fetal growth and increased fetal 54 
abnormalities (Wyman, Pinto et al. 2008).  Hyperglycaemia during oocyte maturation 55 
and early development is associated with altered intracellular parameters, such as 56 
perturbed meiotic maturation and disrupted mitochondrial distribution (Chang, Dale et 57 
al. 2005; Colton, Pieper et al. 2002), as well as apoptosis in follicular and granulosa 58 
cells (Chang, Dale et al. 2005).  59 
 60 
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The detrimental effects of hyperglycaemia on oocyte developmental competence is in 61 
part mediated by up-regulation of the hexosamine biosynthesis pathway (HBP) (Cheryl 62 
J. Schelbach 2012; Schelbach, Kind et al. 2010; Sutton-McDowall, Mitchell et al. 63 
2006), a fuel-sensing pathway, which metabolises glucose to uridine diphosphate-N-64 
acetylglucosamine (UDP-GlcNAc). Single UDP-GlcNAc molecules modify serine or 65 
threonine amino acids of proteins, a process known as β-O-linked glycosylation (O-66 
GlcNAcylation), which acts in an analogous manner to phosphorylation to regulate 67 
protein function (Butkinaree, Park et al. 2010). Altered O-GlcNAcylation is one of the 68 
primary pathologies of diabetes in somatic cells and notably the primary mechanism 69 
behind the development of insulin resistance in Type II diabetes (Marshall, Bacote et al. 70 
1991; Yang, Ongusaha et al. 2008).  71 
 72 
Glucosamine (GlcN), a known hyperglycaemic mimetic, can be metabolised via the 73 
HBP by bypassing the rate-limiting enzyme of the HBP, glutamine:fructose-6-74 
phosphate amidotransferase (GFPT)  (Nelson, Robinson et al. 2000; Uldry, Ibberson et 75 
al. 2002) hence it is a potent stimulator of HBP pathway activity. We have previously 76 
demonstrated that GlcN supplementation during IVM results in increased O-77 
GlcNAcylation in mouse COCs (Frank, Sutton-McDowall et al. 2014a) and perturbed 78 
oocyte developmental competence in cow, pig and mouse and decreased cleavage rates 79 
in the mouse (Cheryl J. Schelbach 2012; Frank, Sutton-McDowall et al. 2013; Kimura, 80 
Iwata et al. 2008; Sutton-McDowall, Mitchell et al. 2006).  81 
 82 
Hyperlipidemia is also known to cause numerous perturbations in oocyte structure and 83 
developmental competence. Female mice fed a high-fat-diet (HFD) have higher rates of 84 
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anovulation, smaller and fewer mature oocytes, increased lipid accumulation, altered 85 
mitochondrial activity and decreased rates of oocyte nuclear maturation and fertilisation 86 
compared to oocytes derived from control mice (Igosheva, Abramov et al. 2010; 87 
Jungheim, Schoeller et al. 2010; Luzzo, Wang et al. 2012; Wu, Dunning et al. 2010). 88 
Increased lipid accumulation induces lipotoxicity, which causes damage to cellular 89 
organelles, particularly mitochondria and endoplasmic reticulum (ER). A biomarker of 90 
lipotoxicity is the ER-stress, characterised by the accumulation of misfolded proteins 91 
and consequently triggering the unfolded protein response (UPR) (Alhusaini, McGee et 92 
al. 2010; Wu, Norman et al. 2011).  93 
 94 
UPR is an attempt by the cell to slow protein production and improve protein folding, 95 
characterized by the induction of several genes, including the markers activating 96 
transcription factor 4  (Atf4), activating transcription factor 6 (Atf6) and glucose-97 
regulated protein 78 (Grp78) (Malhotra and Kaufman 2007). Failure of the UPR will 98 
eventually initiate the lipotoxicity pathways and potentially culminate in apoptotic cell 99 
death. COCs from mice fed a HFD were shown to have increased expression of ER 100 
stress marker genes Atf4 and Grp78, similar to those matured in lipid-rich follicular 101 
fluid (Wu, Dunning et al. 2010; Yang, Wu et al. 2012). Similar events happen in 102 
women, with increased Atf4 expression observed in granulosa cells of obese women 103 
(Wu, Dunning et al. 2010). 104 
 105 
A link between the HBP and ER-stress has been suggested in somatic cells (Lombardi, 106 
Ulianich et al. 2012; Sage, Walter et al. 2010; Srinivasan, Tatu et al. 2009), with 107 
increasing activity through the HBP increasing the transcript and translocation of ER-108 
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stress markers. However, little is known about how hyperglycaemia and lipid 109 
conditions impact reproductive function, in particular pre-implantation embryo 110 
development. Furthermore, it is also unclear if these metabolic perturbations operate 111 
through the same or different mechanisms. The aim of this study was to examine the 112 
impact of hyperglycaemia and lipid supplementation on mouse oocyte developmental 113 
competence. We hypothesised that combination of lipid and high glucose leads to the 114 
accumulation of HBP product, UDP-GlcNAc, by increasing -O-linked glycosylation 115 
and activating the ER-stress pathway.  116 
 117 
Materials and methods 118 
Mice 119 
Female CBA F1 mice were obtained at 21 days old from the University of Adelaide 120 
(Waite campus) and kept in the Animal House at the Medical School, the University of 121 
Adelaide, North Terrace campus, under a 14h:10h light:dark cycle with ad libitum 122 
access to food and water. All animal experiments were approved by the University of 123 
Adelaide’s Animal Ethics Committee (Medical) and were conducted in accordance with 124 
the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. 125 
 126 
Isolation and in vitro maturation of mouse COCs 127 
Immature, unexpanded COCs were isolated by puncturing the antral follicles of ovaries 128 
collected 46 h post-intraperitoneal injection of 5IU pregnant mare’s serum gonadotropin 129 
(PMSG; Folligon; Intervet, Boxmeer, The Netherlands). All COCs were collected in 130 
HEPES-buffered -MEM handling media (Life Technologies, Invitrogen, CA, USA) 131 
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supplemented with 4 mg mL
-1
 fatty acid free Bovine Serum Albumin (FAF BSA; MP 132 
Biomedicals, Solon, OH, USA). Immature COCs were cultured in groups of 30 in 1.5 133 
mL of pre-equilibrate IVM medium, overlaid with paraffin oil (Merck, Darmstadt, 134 
Germany). Base IVM media (control) was bicarbonate-buffered -MEM supplemented 135 
with 1% fetal bovine serum (FBS; Invitrogen, Gibco, Victoria, Australia), 50 mIU mL
-1
 136 
recombinant human follicle stimulating hormone (FSH; Puregon-Organon, Oss, The 137 
Netherlands) and 10 ng mL
-1
 recombinant human epidermal growth factor (EGF; R & 138 
D Systems). Experimental treatments were 1) Control (5.56 mM glucose); 2) high 139 
glucose (30 mM glucose); 3) glucosamine (2.5 mM GlcN plus 5.56 mM glucose); 4) 140 
lipid (40 M lipid concentrate; GIBCO, Invitrogen, CA, USA) and 5) lipid and high 141 
glucose (40 M lipid concentrate plus 30 mM glucose). COCs were cultured at 37 C in 142 
an atmosphere of 6% CO2, 5% O2 and 89% N2 for 8 h or 16 h. We have previously 143 
demonstrated that large culture volumes are required to maintain hyperglycaemic 144 
concentrations of glucose, due to the high metabolic rate of COCs (Frank, Sutton-145 
McDowall et al. 2013). In this study, 30 mM was used to avoid depletion to more 146 
normoglycaemic levels during the course of maturation (Sutton-McDowall, Gilchrist et 147 
al. 2010). Lipid concentrate was diluted 1 in 25, calculated to result in a final 148 
concentration of 40 µM. See Table 1 for composition of the lipid concentrate. 149 
 150 
Development of the lipid accumulation model 151 
A dose response experiment was performed to determine the optimum concentration of 152 
the lipid concentrate (0, 5, 10 20, 40μM). After 16 h of culture, COCs were fixed in 4% 153 
paraformaldehyde in phosphate buffered saline (PBS) for 1 h, washed in PBS and 154 
transferred to 1 g mL-1 of the neutral lipid stain BODIPY 493/503 (Life Technologies, 155 
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Invitrogen, CA, USA) in PBS for 1 h in the dark at room temperature. COCs were 156 
washed in PBS for 5 min and mounted on coverslips in 3 L of DAKO fluorescent 157 
mounting media (Dako North America Inc, CA, USA). Images were captured using a 158 
Fluoview FV10i confocal microscope (Olympus; Tokyo, Japan) using a green laser 159 
(excitation: 480 nm, emission: 515 nm) and identical magnification, image and laser 160 
settings were used throughout experiments (See Fig. S1 available as Supplementary 161 
Material to this paper). Two replicates were performed. 162 
 163 
Assessment of cumulus expansion index (CEI) 164 
Cumulus expansion was assessed after 16 h of culture by an independent assessor, 165 
blinded to treatments, using a scale previously described (Vanderhyden, Caron et al. 166 
1990). Briefly, a score of 0 indicated no expansion of cumulus cells; +1 = the outer 167 
most layers of cumulus cells expanded; +2 = expansion of the entire outer half of 168 
cumulus cells; +3 = all layers expanded except the corona radiatae, and +4 = maximal 169 
expansion of all layers of cumulus cells. For each treatment group, a mean cumulus 170 
expansion index (CEI) (0.0-4.0) was calculated. Three replicates were performed, 171 
averaging 25 COCs per treatment group and replicate. 172 
 173 
In vitro fertilisation (IVF) and assessment of embryo development 174 
Following 16 h of maturation, COCs were washed once in fertilisation medium 175 
(VitroFert, Cook Australia, Brisbane, Australia) and COCs were transferred to pre-176 
equilibrated fertilisation drops overlaid with paraffin oil. Male mice, which had 177 
previously been assessed for mating ability (not less than 3 days prior), were used as 178 
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sperm donors for IVF. Mice were sacrificed by cervical dislocation and the 179 
epididymides and vasa deferentia were collected into warm (37 C) wash medium 180 
(VitroWash, Cook Australia), cleaned of excess fat and tissue and transferred into 1 mL 181 
of fertilisation media. Sperm were extracted into the medium and allowed to capacitate 182 
at 37 C in an atmosphere of 6% CO2, 5% O2 and 89% N2 for 1 h. Capacitated sperm 183 
(10 L) was added to 90 L fertilisation drops and COCs and sperm were co-incubated 184 
for 4 h at 37 C in an atmosphere of 6% CO2, 5% O2 and 89% N2. COCs were 185 
transferred to wash medium, cumulus cells removed mechanically by repeat pipetting. 186 
Presumptive zygotes were washed in embryo culture medium (VitroCleave, Cook 187 
Australia) and placed into culture drops (4 – 7 per 10 L drop) at 37 C in an 188 
atmosphere of 6% CO2, 5% O2 and 89% N2. Twenty-four hours following IVF (Day 2), 189 
the fertilisation rate was assessed and 2-cells embryos were transferred onto a fresh 20 190 
L drop of embryo culture medium. Embryo morphology was assessed on Day 5 (the 191 
end of culture period, 96-100 h post-fertilisation). On-time embryo development was 192 
assessed on Day 2 (expected 2-cell stage) and Day 5 (blastocysts or hatching 193 




Following IVM (16 h), COCs were fixed in 4% paraformaldehyde in PBS overnight. 198 
Whole COCs were adhered on Cell-Tak (BD Biosciences)-coated slides and 199 
immunohistochemically stained using the primary antibody, CTD110.6 (anti O-GlcNAc 200 
antibody; Covance, NJ, USA) for O-GlcNAc and propidium iodide (PI) for nuclear 201 
staining. Briefly, COCs were permeabilised for 30 min in 0.25 % Triton X-100 (United 202 
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States Biochemical Corp., OH, USA), blocked for 2 h using 10% goat serum in PBS 203 
(Jackson Immuno, PA, USA) in PBS and incubated overnight at 4˚C with 1:250 204 
CTD110.6 in blocking solution at. On day 2, COCs were washed and incubated for 2 h 205 
at room temperature with 1:250 Alexa Fluor 488 goat anti-mouse IgM (Invitrogen, CA, 206 
USA) in blocking solution, washed twice in PBS/PVP and 30 minutes with PI, and 207 
mounted under a coverslip in 3 L of DAKO fluorescent mounting media (Dako). 208 
Fluorescence intensity and localisation was examined using Fluoview FV10i confocal 209 
microscope using the Alexa Fluor 488 filter for CTD110.6 (excitation: 488 nm, 210 
emission: 519 nm) and the PI filter (excitation: 488nm, emission: 617 nm). Three 211 
replicates were performed, with 10 COCs per treatment group. Localisation and 212 
intensity of CTD110.6 positive staining across the COC was determined using Image J 213 
software by placing a box across the oocyte and cumulus cells image and measuring 214 
pixel intensity. The mean fluorescence intensity in each pixel column was reported and 215 
mean ± SEM was calculated. The data was then represented graphically as intensity of 216 
fluorescence over pixel widths (Wu, Dunning et al. 2010). Total O-linked-glycosylated 217 
protein was determined as the sum of total fluorescence in the boxed area. 218 
 219 
RNA isolation and real-time RT-PCR 220 
Following 8 or 16 h IVM, groups of 90-100 COCs were collected in a minimal volume 221 
of medium, snap frozen in liquid nitrogen and stored at -80 C. Total RNA was isolated 222 
from COC using TRIzol Reagent (Invitrogen, CA, USA) method, followed by DNase 223 
treatment using Ambion kit (Invitrogen, CA, USA) as per manufacturer’s instructions. 224 
RNA concentration and purity were quantified using a Nanodrop ND-1000 225 
Spectrophotometer (Biolab, Carmel, IN) before reverse transcribing 600 ng of RNA 226 
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using random primers (Invitrogen, CA, USA) and Superscript III Reverse 227 
Transcriptase (Invitrogen, CA, USA) according to the manufacturer’s instructions. 228 
Ribosomal protein RPl19 (QIAGEN) was used as a validated internal control for every 229 
sample. Xbp1s primers were: Xbp1s reverse, 5’-AGG CTT GGT GTA TAC ATG G-3’ 230 
and Xbp1s forward, 5’-GGT CTG CTG AGT CCG CAG GAG G-3’ (Ozcan, Ergin et al. 231 
2009), and the other primers were Quantitect Primer assays (QIAGEN). Real-time RT-232 
PCR was performed in quadruplicate using SYBR green PCR Master Mix (Applied 233 
Biosystems, Foster City, CA) and a Rotor-Gene 6000 (Corbett, Valencia, CA) real-234 
time rotary analyser. Real-time RT-PCR data were analysed using the 2
-(CT)
 method 235 
and expressed as the fold change relative to a calibrator sample, which was included in 236 
each run. Eight replicates were performed for the control treatment and four replicates 237 
were performed for all other treatments, with 90-100 COCs per treatment group and 238 
replicate. 239 
 240 
Statistical analysis 241 
Statistical analysis was performed using Graph Pad Prism version 5.0 (GraphPad 242 
Software, La Jolla California USA). Differences between treatment groups were tested 243 
using a general linear model, followed by Bonferroni post hoc tests. Cleavage and 244 
blastocyst rates were arcsine transformed prior to analyses. Outcome parameters are 245 
reported as mean  SEM. A P value of < 0.05 was considered statistically significant. 246 
 247 
Results 248 
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Experiment 1: Lipid and hyperglycaemic mimetic, GlcN, impaired oocyte 249 
developmental competence.  250 
Cumulus expansion indices (CEI) were examined prior to IVF. Hyperglycaemia and 251 
lipid treatments during IVM imposed no effect on cumulus expansion (P > 0.05; Table 252 
2). On day 2, the cleavage rate of COCs treated with high glucose + lipid was 253 
significantly lower than the lipid treatment (high glucose + lipid = 81.86  1.88% vs. 254 
lipid = 89.86  2.06%; P < 0.05). There were no significant differences in cleavage 255 
rates between the other treatment groups. The fertilised oocytes from COCs treated with 256 
GlcN and lipid yielded fewer blastocysts on day 5 (48.49  5.19% and 50.35 ± 4.93% 257 
respectively), which were significantly lower than the control (69.28 ± 3.29%; P < 0.05).  258 
High glucose + lipid treatments trended toward a lower blastocyst rate when compared 259 
to the control (Fig. 1; P = 0.08). 260 
 261 
Experiment 4: O-linked glycosylation is primarily localised in the oocyte in a 262 
mouse model of hyperglycaemia and lipid treatment 263 
Immunohistochemical localisation of O-GlcNAc with CTD110.6 revealed positive 264 
staining in the oocytes, with higher intensity in COCs treated with high glucose, lipid, 265 
GlcN and high glucose + lipid treatments compared to the control (Fig.2A). 266 
Densitometry analysis of the CTD110.6 revealed similar results, where GlcN treatment 267 
significantly increased O-glycosylation positive staining within the oocyte compared to 268 
the control group (Fig. 2B; P < 0.05). Increased O-glycosylation was also observed in 269 
the oocytes treated with high glucose.  In contrast, addition of lipid with high glucose 270 
diminished the extent of staining relative to glucose alone. No significant difference 271 
was observed in the cumulus cells between the treatment groups (Fig. 2B). 272 
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 273 
Experiment 5: Expression of hexosamine biosynthetic pathway (HBP) enzymes 274 
and endoplasmic reticulum (ER) stress genes following exposure to 275 
hyperglycaemia and lipids 276 
The mRNA expression of HBP enzymes glutamine:fructose-6-phosphate 277 
amidotransferase 1 (Gfpt1), Gfpt2, O-linked -N-acetylglucosaminyltransferase (Ogt) 278 
and hyaluronan synthase 2 (Has2) were determined following exposure to high glucose 279 
and lipid treatments. After 8 h of maturation, GlcN treatment resulted in 2.2-fold 280 
increase in Gfpt1, 2.8-fold increase in Gfpt2 and 4-fold increase in Has2 expressions 281 
compared to the control group (Fig. 3A-B, 3D). There were no other significant 282 
differences in gene expression between the other treatment groups (Fig. 3). After 16 h, 283 
there was a corresponding increased expression of Gfpt1 (1.8-fold) and Gfpt2 (1.4-fold) 284 
(Fig. 3A-B) for the GlcN treatment. Interestingly, addition of lipid to the culture 285 
medium significantly decreased the expression of Ogt (an enzyme that adds the O-286 
GlcNAcylation to proteins) and Gfpt2 when compared to the control (Fig. 3B-C). 287 
 288 
After 8 h of maturation, supplementation of GlcN in the culture media resulted in 289 
increased expression of ER-stress gene Grp78 (3-fold), whereas lipid treatment 290 
significantly increased Atf4 expression (Fig. 4A-C). After 16 h, a similar trend was 291 
observed in the gene expression level with increased Xbp1 (1.8-fold) and Grp78 (2.6-292 
fold) following GlcN treatment (Fig. 4A, 5C). Lipid and high glucose + lipid treated 293 
COC also significantly increased the expression of Xbp1 (1.8-fold). At this time point, 294 
COCs treated with GlcN (2.3-fold) and high glucose (1.5-fold) were found to have up-295 
regulated the expression of Atf4. Interestingly, Atf4 expression was significantly 296 
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reduced when lipid was added to the high glucose culture medium. There were no 297 
significant differences in Atf6 gene expression between treatment groups (Fig.4D). 298 
 299 
Discussion 300 
There is a significant body of literature that demonstrates poor pre-implantation embryo 301 
development outcomes following hyperglycaemic or lipidemic exposure during in vivo 302 
or in vitro development. The current study elucidates some of the cellular mechanisms 303 
by which high glucose and lipid conditions contribute to reduced oocyte quality and 304 
developmental competence. In this study, we utilised a chemically defined lipid 305 
concentrate that contains various non-esterified fatty acids (NEFAs) as a substitution of 306 
using single lipids such as palmitic acid or lipid-rich follicular fluid, which were used in 307 
other studies (Aardema, Vos et al. 2011; Wu, Russell et al. 2012; Yang, Wu et al. 2012). 308 
This was because the lipid concentrate is more closely resembled the NEFA detected in 309 
women with increased body mass index (Robker, Akison et al. 2009; Valckx, De Pauw 310 
et al. 2012) and that follicular fluid contains hormones, growth factors and undefined 311 
proteins which may compromise development. Furthermore, we have investigated the 312 
role of high glucose and lipid on O-GlcNAcylation and ER-stress during and at the end 313 
of IVM. Notably, hyperglycaemic conditions increase aberrant O-linked glycosylation 314 
in the oocytes and induce the expression of ER-stress genes. Surprisingly, presence of 315 
lipid in the culture media represses the expression of HBP enzymes genes such as the 316 
rate-limiting enzyme Gfpt2 and Ogt. 317 
 318 
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The cleavage rate of COCs treated with the combination of high glucose and lipid was 319 
lower than treatment with lipid alone, whereas blastocyst development was significantly 320 
reduced following GlcN and lipid supplementation, but only tended to decrease in high 321 
glucose. This discrepancy with high glucose treatment may be explained by the 322 
difference in culture media used; a much simpler medium was utilised in our previous 323 
study (Frank, Sutton-McDowall et al. 2013). The result with lipid treatment is 324 
consistent with several other publications, demonstrating that lipid level is critical 325 
during embryo development (Leroy, Vanholder et al. 2005; Van Hoeck, Sturmey et al. 326 
2011; Wu, Russell et al. 2012; Yang, Wu et al. 2012). Interestingly, there was a trend of 327 
decreased blastocyst development following culture with high glucose + lipid 328 
suggestive of high levels of glucose not having an additive impairment of oocyte 329 
developmental competence. 330 
 331 
Increased -O-GlcNAcylation of proteins is a hallmark of increased HBP activity, 332 
induced by either hyper- or hypoglycemia. Following IVM, high glucose or GlcN 333 
significantly increased -O-GlcNAcylation levels, in line with GlcN being a potent 334 
stimulator of HBP UDP-GlcNAc production (approximately 40 times, as measured in 335 
adipocytes (Marshall, Bacote et al. 1991)). Excess flux with either glucose or GlcN 336 
through HBP has previously shown to reduce embryo development and this 337 
phenomenon was reversed using an OGT inhibitor, reflecting their relative potential to 338 
stimulate HBP and UDP-GlcNAc production (Frank, Sutton-McDowall et al. 2014a; 339 
Frank, Sutton-McDowall et al. 2014b; Pantaleon, Tan et al. 2010). The addition of lipid 340 
to the medium did not increase O-GlcNAcylation levels. This phenomenon could be 341 
explained by the fact that opposing interactions between unsaturated fatty acids (such as 342 
Glucose and lipid on developmental competence
   
 16 
oleic acid) are able to inhibit the pro-apoptotic effect of their counterpart-saturated 343 
palmitic and stearic acid (Nemcova-Furstova, James et al. 2011).  344 
 345 
There were no additive effects of high glucose and lipid on -O-GlcNAcylation. Indeed, 346 
intensity within the oocyte the in lipid and high glucose group was overall reduced 347 
compared to high glucose treated COCs. Under the in vitro conditions used, lipid 348 
appears to play a role in down-regulating cellular responses to hyperglycaemia. 349 
Hyperglycaemia is a characteristic of both types of diabetes, yet hyperlipidemia is only 350 
associated with Type II diabetes.  Although the current study utilises an in vitro model, 351 
we have also found that systemic administration of GlcN during the peri-compaction 352 
period had significant effects on fetal survival and abnormalities, which were most 353 
evident in lean rather than obese mice, indicating the possibility that high lipid and 354 
glucose levels may interact and regulate fuel-sensing pathways, specifically the HBP 355 
(Schelbach, Robker et al. 2013). 356 
 357 
Compared to the control group, GlcN treatment significantly increased mRNA 358 
expression of the rate-limiting enzyme of HBP, Gfpt1 and Gfpt2 after 8 and 16 h of 359 
culture. While high glucose treatment did not affect the gene expression of HBP 360 
enzymes (possibly due to glucose regulation of these enzymes being at the substrate 361 
availability and post-translational level), expression of Gfpt2 and Ogt (the enzyme that 362 
modifies proteins with GlcNAc) were down regulated in the lipid group compared to 363 
the control, supportive of the notion that lipids interact with glucose sensing pathways. 364 
Previously, elevated fatty acids have been shown to interfere with glucose by inhibiting 365 
glucose-induced insulin secretion and -cell oxidation in rat pancreatic islets (Sako and 366 
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Grill 1990; Zhou and Grill 1994). Moreover, free fatty acids supplementation decreases 367 
the expression of glucose transporter type 2 (SLC2A2) and glucokinase (Gremlich, 368 
Bonny et al. 1997). Therefore, down-regulation of HBP enzymes in the presence of 369 
lipids may be due to impaired glucose transporter activities, reducing glucose 370 
transportation down the pathway and decreasing the production of UDP-GlcNAc, the 371 
end product of HBP. Alternatively, the level of UDP-GlcNAc may also be limited by 372 
the known feedback inhibition of Gfpt by UDP-GlcNAc (Kornfeld 1967). All these 373 
interactions of lipid with glucose further supported the idea that nutrient-sensing 374 
pathways are also interconnected in the ovary/COC/ovarian cells. While O-375 
GlcNAcylation staining revealed maximal staining in the oocyte, should the differences 376 
in gene expression are due to changes in the oocytes or the surrounding cumulus cells. 377 
Oocyte exhibits low transcriptional activity, however, bidirectional communication 378 
between oocyte and cumulus cells are essential for oocyte viability (Albertini, 379 
Combelles et al. 2001; Eppig 1991). So, alteration in cumulus cells should reflect in the 380 
oocytes. 381 
 382 
The induction of ER-stress is a well-characterised response of lipotoxicity (Borradaile, 383 
Han et al. 2006; Malhi and Gores 2008). Consistent with previous studies, Xbp1 and 384 
Atf4 were specifically up-regulated in COC following lipid treatment (Wu, Russell et al. 385 
2012; Yang, Wu et al. 2012). GlcN treatment significantly increased mRNA expression 386 
of Xbp1, Atf4 and Grp78 suggesting that the COC is undergoing a distinct UPR 387 
response or that its presence influences the stress response. Interestingly, high glucose 388 
significantly increased the expression of Atf4 after 16 h of culture, which was down-389 
regulated in the high glucose and lipid treatment, further emphasising that lipid appears 390 
to inhibit the effect induced by hyperglycaemia. In contrast, the Atf6 expression 391 
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remained unaffected by all the treatments at both time points. Activation of Atf6 392 
requires a dissociation step from its inhibitory regulator, Binding immunoglobulin 393 
Protein (BiP). Binding of Atf6 to BiP was reported to be very stable (Shen, Snapp et al. 394 
2005), thus could explain why there was no activation of this pathway in response to the 395 
treatments. 396 
 397 
In summary, the current findings demonstrated that lipid at level of 40 M (and GlcN) 398 
induced ER stress and that high glucose (and GlcN) increase O-GlcNAcylation but that 399 
the two treatments do not potentiate each other in these pathways. Furthermore, this 400 
study also implicates the possibility of lipid down-regulating the detrimental 401 
consequences of hyperglycaemia on oocyte health. This study also implicates the 402 
mechanism of O-GlcNAcylation and ER stress as likely contributors to the reduced 403 
fertility observed in obese women.  This provides new leads for further investigation 404 
into possible treatment strategies and interventions which may improve pregnancy and 405 
fetal outcomes in obese women and its associated comorbidities such as diabetic 406 
women. 407 
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Figure legends 641 
Figure 1. Cleavage and blastocyst development following IVM in high glucose, 642 
lipids or glucosamine (GlcN). Data are presented as the mean + SEM. Different letters 643 
indicate significance differences (
ab,xy 
P < 0.05). GlcN = Glucosamine. 644 
 645 
Figure 2A. Localisation of β-O-linked glycosylation in COCs following IVM in the 646 
presence of high glucose and lipid. Propidium iodide (PI, red) shows nuclear staining, 647 
CTD 110.6 (green) shows -O-glycosylation (O-GlcNAc). The images were merged 648 
(merge). Scale bars = 100 m. GlcN = Glucosamine. 649 
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 650 
Figure 2B. Intensity of CTD110.6 after cultured with different treatments. 651 
COCs were collected after 16 h of culture with control and glucose, fixed in 4% 652 
paraformaldehyde and incubated with CTD110.6 for -O-glycosylation (O-GlcNAc) 653 
and propidium iodide (PI) for nuclear staining. Values are mean  SEM (lighter shading 654 
represents error bars). Asterisks indicate significance differences compared to the 655 
control. ****P<0.0001, ***P<0.001, **P<0.01, *P<0.05. GlcN = Glucosamine. 656 
 657 
 658 
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Figure 3. Expression of HBP enzymes after 8 and 16 hours of IVM. 659 
COCs were collected after 8 h and 16 h of culture with different treatments. Total RNA 660 
was isolated, reverse transcribed and expression of HBP enzymes (A) 661 
Glutamine:Fructose-6-phosphate transaminase 1 (Gfpt1), (B) Glutamine:Fructose-6-662 
phosphate transaminase 2 (Gfpt2), (C) O-linked glycosyltransferase (Ogt) and (D) 663 
hyaluronan synthase 2 (Has2) (D) were analysed by RT-PCR. Values are mean  SEM 664 
expressed as a fold change relative to Rpl19. Different letters indicate significant 665 
differences (
ab 
P < 0.05). GlcN = Glucosamine. 666 
 667 
Figure 4. Expression of ER stress marker genes after 8 and 16 hours of IVM. 668 
COCs were collected after 8 h and 16 h of culture with different treatments. Total RNA 669 
was isolated, reverse transcribed and expression of ER stress marker genes (A) X-box-670 
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binding protein-1 (Xbp1), (B) Activating transcription factor 4 (Atf4), (C) glucose-671 
regulated protein 78 (Grp78) and (D) Activating transcription factor 4 (Atf6) were 672 
analysed by RT-PCR. Values are meanSEM expressed as a fold change relative to 673 
Rpl19. Different letters indicates significant differences by one-way ANOVA, 674 
Bonferroni post hoc test. 675 
 676 
Figure S1. BODIPY lipid staining following IVM in increasing doses of lipid.  677 
COCs were matured for 16 hours in IVM in medium containing various concentrations 678 
of defined lipid concentrate and stained with neutral lipid dye BODIPY 490/503. (A) 0 679 
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M lipid; (B) 5 M lipid; (C) 10 M lipid; (D) 20 M lipid; (E) 40 M lipid. Scale bars 680 
= 100 m. 681 
682 
  683 
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Table 1. Chemically Defined Lipid concentrate used in lipid treatment during in vitro 684 
maturation  685 
Components Concentration (mg/L) 
Arachidonic Acid 20 
Cholesterol 220 
DL-alpha-Tocopherol Acetate 70 
Ethyl Alcohol 100% 0 
Linoleic Acid 10 
Linolenic Acid 10 
Myristic Acid 10 
Oleic Acid 10 
Palmitic Acid 10 
Palmitoleic Acid 10 
Pluronic F-68 90000 
Stearic Acid 10 
Tween 80® 2200 
  686 
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Table 2. Cumulus expansion indices following maturation (16 h) in the inidictaed 687 
treatments. 688 
Treatment Cumulus expansion index  
Control 3.81  0.14 
Glucose 3.84  0.10 
Lipid 3.68  0.03 
Glucose + Lipid 3.63  0.07 
GlcN 3.89  0.07 
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